Literature DB >> 7441209

Mutational changes of the protease susceptibility of glycoprotein F of Newcastle disease virus: effects on pathogenicity.

W Garten, W Berk, Y Nagai, R Rott, H D Klenk.   

Abstract

Two chemically induced mutants with an alteration in the susceptibility of glycoprotein F to proteolytic cleavage have been isolated from the apathogenic strains of La Sota and Ulster of Newcastle disease virus. In contrast to the La Sota wild type, cleavage of the precursor F0 and activation of cell fusing activity and infectivity take place if the mutant is grown in MDBK and BHK21-F cells. The mutant is, therefore, able to undergo multiple replication cycles in cells non-permissive for the wild type. This increase in host range is paralleled by an increase in pathogenicity for chick embryos. The increase in host range of the Ulster mutant is less distinct. This mutant, which does not differ in pathogenicity from its wild type, produces in MDBK cells incompletely activated virus containing predominantly glycoprotein HN in the uncleaved and glycoprotein F in the cleaved form. The data support the concept that the susceptibility of the virus glycoproteins to proteolytic activation is an important factor in determining the pathogenicity of this virus.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7441209     DOI: 10.1099/0022-1317-50-1-135

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  22 in total

1.  Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro.

Authors:  B Dietzschold; T J Wiktor; J Q Trojanowski; R I Macfarlan; W H Wunner; M J Torres-Anjel; H Koprowski
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

2.  Deduced amino acid sequences surrounding the fusion glycoprotein cleavage site and of the carboxyl-terminus of haemagglutinin-neuraminidase protein of the avirulent thermostable vaccine strain I-2 of Newcastle disease virus.

Authors:  P N Wambura; J Meers; J A Kattenbelt; A R Gould; P B Spradbrow
Journal:  Vet Res Commun       Date:  2006-12-29       Impact factor: 2.459

Review 3.  Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.

Authors:  Dmitriy Zamarin; Peter Palese
Journal:  Future Microbiol       Date:  2012-03       Impact factor: 3.165

Review 4.  Protease-dependent virus tropism and pathogenicity.

Authors:  Y Nagai
Journal:  Trends Microbiol       Date:  1993-06       Impact factor: 17.079

5.  Differentiation of mumps virus strains with monoclonal antibody to the HN glycoprotein.

Authors:  A C Server; D C Merz; M N Waxham; J S Wolinsky
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

6.  Viral glycoproteins as determinants of pathogenicity.

Authors:  H D Klenk; W Garten; F X Bosch; R Rott
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

7.  Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs.

Authors:  M Tashiro; M Homma
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

8.  Pathogenicity and immunogenicity in chickens of Newcastle disease viruses isolated from wild ducks. Brief report.

Authors:  M Kawamura; T Mikami; H Kodama; H Izawa
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

9.  Separation and sugar component analysis of the oligosaccharides in the surface glycoproteins of Newcastle disease virus.

Authors:  S Diabaté; R Geyer; S Stirm
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

10.  Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.

Authors:  Yiu-Wing Kam; Yuushi Okumura; Hiroshi Kido; Lisa F P Ng; Roberto Bruzzone; Ralf Altmeyer
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.